To determine the target proteins of Ainsliadimer A (AIN)-treated MCF-7 cells, all direct or indirect targets were identified by thermosensitive proteome analysis of AIN using a multiple quantitative mass spectrometry, and the proteomic profiles of Ainsliadimer A after acting on MCF-7 cancer were analyzed by label quantification.